Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 34 Issue 5
. 
Turn off MathJax
Article Contents
Abstract
References
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2016  >  34(5): 403-407,415

GAO Yue, CHEN Anni, ZHAO Yahong, XUE Dan, AN Yongtong, CHAI Yifeng, ZHANG Hai. Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(5): 403-407,415. doi: 10.3969/j.issn.1006-0111.2016.05.006
Citation: GAO Yue, CHEN Anni, ZHAO Yahong, XUE Dan, AN Yongtong, CHAI Yifeng, ZHANG Hai. Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(5): 403-407,415. doi: 10.3969/j.issn.1006-0111.2016.05.006
shu

Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury

doi: 10.3969/j.issn.1006-0111.2016.05.006
  • 1.

    Center of Experimental Teaching, College of Pharmacy, Second Military Medical University, Shanghai 200433, China

  • 2.

    Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital of Second Military Medical University, Shanghai, 200438, China

  • 3.

    Central Research Institute, Shanghai Pharmaceuticals Holding Co.Ltd., Shanghai 200123, China

  • Received Date: 2016-07-20
  • Rev Recd Date: 2016-08-23
  • Objective Experimental study on effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury in order to provide a theoretical basis for its clinical application. Method Rat model of chronic ischemic heart failure and acute ischemia reperfusion mouse model of myocardial infarction were constructed through coronary artery ligation. Those animals were randomized to sham operation group, model group, positive drug group, high Yangxinshi tablet dose group, middle Yangxinshi tablet dose group, low Yangxinshi tablet dose group. Rat electrocardiogram, ultrasound, ACE, ACD, TNF-a, mouse myocardial infarction area, CK, LDH, SOD and related factors were recorded during pre-dosing and post-dosing after modeling. Morphological changes were observed with cardiac pathological section. Results The biochemical indicators in model group were significantly different from sham operation group with statistical significance (P<0.001). Compared to the model group, positive drug group and high Yangxinshi tablet dose group exhibited biochemical differences with statistical significance (P<0.001, P<0.01, P<0.05), significant myocardial infarction area reduction (P<0.01, P<0.05), improvement in myocardial cells and reduction in the cell infiltration. Conclusion Yangxinshi tablets have preventive and therapeutic effects on chronic ischemic heart failure and acute ischemia reperfusion injury.
  • [1] 姜作玲,高 莉, 王 辉,等.养心氏片对大鼠冠脉结扎致心肌缺血模型的影响[J].世界中医药,2015,10(4):553-556.
    [2] 崔 燕,张 辉,庄 婕.养心氏片治疗心绞痛及冠心病临床试验资料研究[J].食品与药品, 2013,15(4):293-295.
    [3] 盘 锋.养心氏片辅助治疗舒张性心力衰竭80例疗效观察[J].中医临床研究,2014,6(18):39-41.
    [4] 瞿家武,虞江灏.养心氏片治疗慢性心力衰竭临床疗效观察[J].实用临床医药杂志,2010,14(15):89-97.
    [5] 王 靓,黄金玲,施 慧,等.对慢性心力衰竭实验动物模型制作方法的研究进展[J].当代医药论丛,2014,12(10):291-293.
    [6] 韩 曼,马 莉,于远望.2种慢性心力衰竭大鼠模型的建立[J].新乡医学院学报,2015,32(11):992-995.
    [7] 刘 建,范慧敏,汪进益,等.小鼠心梗模型的建立与无创评价[J].中国实验动物学报,2010,18(3):196-198.
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0400.250.50.7511.25Highcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 86.3 %FULLTEXT: 86.3 %META: 10.8 %META: 10.8 %PDF: 2.9 %PDF: 2.9 %FULLTEXTMETAPDFHighcharts.com
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 22.3 %其他: 22.3 %其他: 0.2 %其他: 0.2 %China: 1.8 %China: 1.8 %United States: 0.2 %United States: 0.2 %[]: 0.2 %[]: 0.2 %上海: 0.9 %上海: 0.9 %东莞: 0.2 %东莞: 0.2 %中卫: 0.2 %中卫: 0.2 %仙桃: 0.2 %仙桃: 0.2 %北京: 22.5 %北京: 22.5 %十堰: 0.2 %十堰: 0.2 %南京: 0.5 %南京: 0.5 %南通: 0.2 %南通: 0.2 %厦门: 0.5 %厦门: 0.5 %合肥: 0.2 %合肥: 0.2 %哈尔滨: 0.2 %哈尔滨: 0.2 %大连: 0.2 %大连: 0.2 %天津: 0.9 %天津: 0.9 %威海: 0.2 %威海: 0.2 %宜春: 0.5 %宜春: 0.5 %广州: 0.2 %广州: 0.2 %张家口: 0.4 %张家口: 0.4 %恩施: 0.2 %恩施: 0.2 %成都: 0.4 %成都: 0.4 %新竹: 0.2 %新竹: 0.2 %晋城: 0.2 %晋城: 0.2 %朝阳: 0.5 %朝阳: 0.5 %杭州: 0.7 %杭州: 0.7 %枣庄: 0.4 %枣庄: 0.4 %柳州: 0.2 %柳州: 0.2 %梧州: 0.2 %梧州: 0.2 %武汉: 0.2 %武汉: 0.2 %洛阳: 0.4 %洛阳: 0.4 %济南: 1.1 %济南: 1.1 %济宁: 0.2 %济宁: 0.2 %淄博: 0.2 %淄博: 0.2 %深圳: 0.2 %深圳: 0.2 %湛江: 0.2 %湛江: 0.2 %漳州: 0.5 %漳州: 0.5 %潍坊: 0.7 %潍坊: 0.7 %珀斯: 0.4 %珀斯: 0.4 %盐城: 0.2 %盐城: 0.2 %石家庄: 0.4 %石家庄: 0.4 %秦皇岛: 0.5 %秦皇岛: 0.5 %绵阳: 0.2 %绵阳: 0.2 %美国伊利诺斯芝加哥: 0.4 %美国伊利诺斯芝加哥: 0.4 %芒廷维尤: 18.2 %芒廷维尤: 18.2 %芝加哥: 0.2 %芝加哥: 0.2 %菏泽: 0.2 %菏泽: 0.2 %衡水: 0.2 %衡水: 0.2 %西宁: 13.5 %西宁: 13.5 %西安: 0.2 %西安: 0.2 %贵阳: 0.4 %贵阳: 0.4 %达尔斯: 0.4 %达尔斯: 0.4 %运城: 0.5 %运城: 0.5 %邢台: 0.2 %邢台: 0.2 %邯郸: 0.2 %邯郸: 0.2 %重庆: 0.7 %重庆: 0.7 %银川: 0.2 %银川: 0.2 %长春: 0.2 %长春: 0.2 %长沙: 1.1 %长沙: 1.1 %长治: 0.2 %长治: 0.2 %阜新: 0.2 %阜新: 0.2 %青岛: 1.4 %青岛: 1.4 %黄冈: 0.7 %黄冈: 0.7 %齐齐哈尔: 0.2 %齐齐哈尔: 0.2 %其他其他ChinaUnited States[]上海东莞中卫仙桃北京十堰南京南通厦门合肥哈尔滨大连天津威海宜春广州张家口恩施成都新竹晋城朝阳杭州枣庄柳州梧州武汉洛阳济南济宁淄博深圳湛江漳州潍坊珀斯盐城石家庄秦皇岛绵阳美国伊利诺斯芝加哥芒廷维尤芝加哥菏泽衡水西宁西安贵阳达尔斯运城邢台邯郸重庆银川长春长沙长治阜新青岛黄冈齐齐哈尔Highcharts.com

  • Cited by

    Periodical cited type(23)

    1. 赵晓峰，邢文龙，刘红旭，尚菊菊，来晓磊，刘庆荣. 养心氏片在冠状动脉介入治疗中应用的系统评价. 中西医结合心脑血管病杂志. 2022(01): 91-94 .
    2. 周琦，邢文龙，刘红旭，尚菊菊，来晓磊，李爱勇，刘庆荣. 养心氏片治疗经皮冠状动脉介入治疗术后胸痛有效性及安全性的Meta分析. 世界中医药. 2022(06): 801-806 .
    3. 王青，卜一珊. 养心氏片联合氯吡格雷治疗冠心病心绞痛的效果观察. 中国药物滥用防治杂志. 2022(10): 1499-1502 .
    4. 唐爱，杨贵志. 养心氏片联合沙库巴曲缬沙坦钠治疗慢性老年心力衰竭患者的临床效果. 中国当代医药. 2021(15): 73-76 .
    5. 刘红旭，林谦，邢文龙. 养心氏片治疗冠心病临床应用专家共识. 中国中西医结合杂志. 2020(01): 5-13 .
    6. 刘红旭，林谦，邢文龙. 养心氏片治疗冠心病临床应用中国专家共识. 中西医结合心脑血管病杂志. 2020(02): 195-202 .
    7. 刘红旭. 《养心氏片治疗冠心病临床应用专家共识》解读. 世界中医药. 2020(04): 637-642 .
    8. Jian LI，Zhixiao WANG，Xinling ZHOU，Yihong JIANG. Advances in Research on Treatment of Heart Failure with Yangxinshi Tablet. Medicinal Plant. 2020(02): 16-20 .
    9. 谢清清，王辉，曹月娟. 养心氏片治疗心血管疾病的研究进展. 世界中医药. 2020(05): 801-804 .
    10. 范瑞云，李文阁，刘艳民，刘平，王辉. 中药养心氏片辅助治疗心功能不全临床效果对比观察. 人民军医. 2020(08): 789-792 .
    11. 范晓艳，张振伟，郭彩杰. 养心氏片联合西药标准化用药治疗PCI后反复心衰患者典型病例分析. 药学研究. 2020(11): 676-679 .
    12. 孙飞龙，袁炜婷，赵高娃，曹雅兰，向姝婷，王钰，于勤. 养心氏对慢性心力衰竭患者心功能及运动中血压和心率影响的研究. 世界中医药. 2019(04): 876-881 .
    13. 张聪，吴宗贵，薛金贵，王贤良. 养心氏片在中西医结合心脏康复中应用的中国专家共识. 中西医结合心脑血管病杂志. 2019(09): 1281-1285 .
    14. 李健，王治校，周鑫玲，姜益宏. 养心氏片治疗心力衰竭研究进展. 世界中医药. 2019(05): 1335-1338 .
    15. 李健，王治校，周鑫玲，姜益宏. 养心氏片治疗心力衰竭研究进展. 世界中医药. 2019(07): 1903-1906 .
    16. 孙飞龙，袁炜婷，胡嘉慧，于勤. 养心氏片对慢性心力衰竭病人运动耐量和生活质量的影响. 中西医结合心脑血管病杂志. 2019(17): 2581-2584 .
    17. 韩琼，韩宏毅，张艳. 心肌缺血患者再灌注损伤的临床治疗进展. 医疗装备. 2018(12): 194-195 .
    18. 郭志刚，于春霞，宋新旗. 养心氏片对心力衰竭大鼠心肌凋亡的影响. 中国老年学杂志. 2018(12): 3032-3035 .
    19. 张强，刘珂，牛红梅，张巍，马丽娟，韩继如. 养心氏片对冠心病心肌PCI术后缺血再灌注损伤的治疗效果. 云南中医学院学报. 2018(02): 15-18 .
    20. 杨凯，马尹梅，周希胜，刘文娟. 芪参益气滴丸联合养心氏片治疗慢性心力衰竭的疗效观察. 现代药物与临床. 2017(11): 2129-2132 .
    21. 姜先昭. 养心氏片治疗缺血性心肌病合并失眠的临床疗效观察. 世界中医药. 2017(07): 1538-1539+1543 .
    22. 张德芹，高学敏，张聪，陆鹏. “养心理论”构建与养心氏片组方理论探析. 中西医结合心脑血管病杂志. 2017(02): 244-247 .
    23. 张文举. 抑郁与慢性缺血性心力衰竭患者C反应蛋白的关系. 中西医结合心血管病电子杂志. 2016(25): 52-53 .

    Other cited types(5)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(4808) PDF downloads(608) Cited by(28)

Related
Proportional views

Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury

doi: 10.3969/j.issn.1006-0111.2016.05.006
  • 1. Center of Experimental Teaching, College of Pharmacy, Second Military Medical University, Shanghai 200433, China
  • 2. Department of Pharmacy, Shanghai Eastern Hepatobiliary Surgery Hospital of Second Military Medical University, Shanghai, 200438, China
  • 3. Central Research Institute, Shanghai Pharmaceuticals Holding Co.Ltd., Shanghai 200123, China
  • Received Date: 2016-07-20
  • Rev Recd Date: 2016-08-23

Abstract: Objective Experimental study on effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury in order to provide a theoretical basis for its clinical application. Method Rat model of chronic ischemic heart failure and acute ischemia reperfusion mouse model of myocardial infarction were constructed through coronary artery ligation. Those animals were randomized to sham operation group, model group, positive drug group, high Yangxinshi tablet dose group, middle Yangxinshi tablet dose group, low Yangxinshi tablet dose group. Rat electrocardiogram, ultrasound, ACE, ACD, TNF-a, mouse myocardial infarction area, CK, LDH, SOD and related factors were recorded during pre-dosing and post-dosing after modeling. Morphological changes were observed with cardiac pathological section. Results The biochemical indicators in model group were significantly different from sham operation group with statistical significance (P<0.001). Compared to the model group, positive drug group and high Yangxinshi tablet dose group exhibited biochemical differences with statistical significance (P<0.001, P<0.01, P<0.05), significant myocardial infarction area reduction (P<0.01, P<0.05), improvement in myocardial cells and reduction in the cell infiltration. Conclusion Yangxinshi tablets have preventive and therapeutic effects on chronic ischemic heart failure and acute ischemia reperfusion injury.

GAO Yue, CHEN Anni, ZHAO Yahong, XUE Dan, AN Yongtong, CHAI Yifeng, ZHANG Hai. Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(5): 403-407,415. doi: 10.3969/j.issn.1006-0111.2016.05.006
Citation: GAO Yue, CHEN Anni, ZHAO Yahong, XUE Dan, AN Yongtong, CHAI Yifeng, ZHANG Hai. Experimental study on the effects of Yangxinshi tablets in the prevention and treatment of chronic ischemic heart failure and acute myocardial ischemia reperfusion injury[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(5): 403-407,415. doi: 10.3969/j.issn.1006-0111.2016.05.006
shu

    HTML

Reference (7)

Catalog

  • HTML

版权所有：《药学实践与服务》编辑委员会

Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

网站备案号 沪ICP备05003363号-1

Supported by: Beijing Renhe Information Technology Co., Ltd.  

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return